Get your COVID-19 vaccine or booster today!
Find out where to get a COVID-19 vaccine, test, or treatment in your community. Call 1-800-232-0233 with questions.COVID.gov
LGBTQI+ Health & Well-being
Join us in advancing equality for LGBTQI+ children and families and preventing discrimination against LGBTQI+ people.
Fostering Drug Competition
Increasing the availability of generic drugs helps to create competition in the marketplace, helping make treatment more affordable and increasing access to healthcare for more patients.
New Era of Smarter Food Safety
A new approach to food safety that recognizes and builds on the progress made in the past but looks towards what processes and tools will be needed for the future.
Mylan Pharmaceuticals Inc., a Viatris Company, Issues Voluntary Nationwide Recall of One Batch of Insulin Glargine (Insulin glargine-yfgn) Injection Pens, 100 units/mL (U-100), Due to the Potential of Missing Labels on Some Pens
Natreve Issues Voluntary Recall on Limited U.S. Batches of Natreve Vegan Protein Powder French Vanilla Wafer Sundae Flavor Due to Undeclared Milk
Food & Beverages
J&M Foods Issues a Voluntary Recall on a Select Lot Number of Lavender Shortbread Cookies Due to the Packages Contain Chocolate Chip Cookies That Do Not Disclose the Correct Allergens
Food & Beverages
FDA’s Center for Devices and Radiological Health’s Continued Efforts to Return to Normal: Reopening for All Pre-Submissions
We continue interactions with device submission sponsors as we work to return to normal operations while continuing to respond to the public health emergency.
FDA's “All-in” Approach to Enterprise Transformation
The Enterprise Modernization Action Plan is the next phase of FDA’s data and technology transformation and describes our plans to shape the agency’s future.
FDA Seeks to Engage Stakeholders on Key Considerations for a Drug Quality Management Maturity Program
Program Aims to Improve Drug Supply Chain, Mitigate Shortages
Animal & Veterinary
DSCSA Standards for the Interoperable Exchange of Information for Tracing of Certain Human, Finished, Prescription Drugs Guidance for Industry